CYNVEC
Cynvec, an early stage biotech company based in New York City, was created in 2004 through the spin out of exclusively licensed IP from New York University focusing on the utility of the sindbis oncolytic viral vector in the treatment of cancer. It is based on the work of Dr. Daniel Meruelo, Ph.D., the world's leading authority on the virus and professor at NYU. Cynvec is in the process of preparing an investigational new drug application (IND) for our first product, CYN 101.
CYNVEC
Industry:
Biotechnology Health Care Medical
Founded:
2004-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.cynvec.com
Total Employee:
1+
Status:
Active
Contact:
+1 (732) 492.1797
Email Addresses:
[email protected]
Total Funding:
2.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Font Awesome Domain Not Resolving Wordpress Plugins
Current Employees Featured
Founder
Official Site Inspections
http://www.cynvec.com Semrush global rank: 5.93 M Semrush visits lastest month: 1.39 K
- Host name: 104.0.153.160.host.secureserver.net
- IP address: 160.153.0.104
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Cynvec"
Cynvec - Crunchbase Company Profile & Funding
Organization. Cynvec . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Cynvec is a biotechnology company that develops …See details»
Cynvec
Cynvec is an innovative biotechnology company that specializes in developing viral immunotherapies. We are developing a proprietary experimental cancer therapy based on the …See details»
About - Cynvec
The SV vectors transit through the lymph nodes where they also actuate and recruit an immune response to trigger cell death of tumor cells through activated NK cells, macrophages and …See details»
Cynvec Company Profile | Management and Employees List
Cynvec was founded in 2004 to develop and commercialize innovative safe and effective cancer treatments based on intellectual property exclusively licensed from New York University …See details»
Cynvec Company Profile 2024: Valuation, Funding & Investors
Who are Cynvec’s investors? National Institutes of Health, National Cancer Institute, Alexander 2006, and The Litwin Foundation have invested in Cynvec. Data Transparency. Meet our data …See details»
Cynvec - Contacts, Employees, Board Members, Advisors & Alumni …
Cynvec is a biotechnology company that develops a proprietary oncolytic technology for the treatment of cancer. Search Crunchbase ... Products. Resources. Pricing. Resources. Log In. …See details»
Cynvec - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Dec 7, 2015: Venture Round - …See details»
Cynvec LLC - Company Profile and News - Bloomberg Markets
Cynvec LLC is a biotechnology company. The Company develops cancer therapies that target cancer cell types including ovarian, pancreatic, GI, liver, and colorectal. ...See details»
Cynvec LLC Company Profile | New York, NY - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Cynvec LLC of New York, NY. Get the latest business insights from Dun & Bradstreet.See details»
Cynvec LLC(SM) Appoints Former Johnson & Johnson Executive
Nov 11, 2008 Cynvec was founded in 2004 and is a development stage biotech company based in New York City. The Company is focused on developing Sindbis-based viral vectors as …See details»
Cynvec - Overview, News & Similar companies | ZoomInfo.com
Cynvec was founded in 2004 to develop and commercialize innovative safe and effective cancer treatments based on intellectual property exclusively licensed from New York University …See details»
Cynvec - Products, Competitors, Financials, Employees, …
Cynvec is an innovative biotechnology company that specializes in developing viral immunotherapies for cancer treatment. Use the CB Insights Platform to explore Cynvec's full …See details»
Cynvec - Crunchbase
Cynvec is a biotechnology company that develops a proprietary oncolytic technology for the treatment of cancer.See details»
CYN-101 - Drug Targets, Indications, Patents - Synapse - Patsnap
CYN-101: a Apoptosis stimulants Drug, Initially developed by Cynvec LLC, Now, its global highest R&D status is Pending, Mechanism: Apoptosis stimulants, Therapeutic Areas: …See details»
Award - SBIR
Official websites use .gov A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock ... NY-ESO-1,andquot;expressed in …See details»
Research programme: anticancer therapies - Cynvec - AdisInsight
Cynvec is developing follow-on immunotherapeutic vaccine products based on the oncolytic sindbis viral (SV) vector, for the treatment of cancer. This vector ... If your organization has a …See details»
Ovarian Cancer – Cynvec
A large proportion of patients do not successfully respond to platinum-based therapies, and 70–90% of women with ovarian cancer will have a recurrence at some point after their …See details»
Cynvec - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Organization. Cynvec . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 25. ... This year, Cynvec is …See details»
CYN-102 - Drug Targets, Indications, Patents - Synapse - Patsnap
CYN-102, Initially developed by Cynvec LLC, Now, its global highest R&D status is Pending, Therapeutic Areas: Neoplasms,Endocrinology and Metabolic Disease,Urogenital Diseases. ...See details»
Cynvec.com Server IP 160.153.0.104 - IP-Tracker.org
Cynvec.com which uses Public IP Address 160.153.0.104 is actually located in United States (US) in North America, as we mentioned above.. Here are a few IP addresses that are part of the …See details»